Blinkered Objections to Bioethics: A Response to Benatar
Journal of Medical Ethics 2005 March; 31(3): 179-180
In a recent commentary, S R Benatar criticised the debates over organ donation and kidney selling for being located within a "narrow and inadequate framework". Benatar levels four charges against those who engage in the current organs debate: that they myopically focus on saving lives; that they accept the dominance of market orientated approaches to health care; that they reify individualism, and that they engage in limited moral arguments. Given the importance of the organs debate it is imperative that the misunderstandings of it on which Benatar's criticisms are based are dispelled. Accordingly, I will consider and reject each of his objections in turn.
Showing items related by title, author, creator and subject.
A "Queen of Hearts" Trial of Organ Markets: Why Scheper-Hughes's Objections to Markets in Human Organs Fail Taylor, J.S. (2007-04)Nancy Scheper-Hughes is one of the most prominent critics of markets in human organs. Unfortunately, Scheper-Hughes rejects the view that markets should be used to solve the current (and chronic) shortage of transplant ...
Germ-Line Therapy for Mitochondrial Disease: Some Ethical Objections [Response to "Germ Line Therapy to Cure Mitochondrial Disease: Protocol and Ethics of In Vitro Ovum Nuclear Transplantation" by Donald S. Rubenstein, David C. Thomasma, Eric A. Schon, and Michael J. Zinaman (CQ Vol. 4, No. 3)] Watt, Helen (1999-01)